Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
25.05
+0.84 (3.47%)
At close: Oct 30, 2026, 4:00 PM EDT
25.74
+0.69 (2.75%)
After-hours: Oct 30, 2026, 7:59 PM EDT
Rapport Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Buy Maintains $62 → $68 | Buy | Maintains | $62 → $68 | +171.46% | Oct 22, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $65 → $70 | Buy | Reiterates | $65 → $70 | +179.44% | Oct 21, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $50 → $82 | Buy | Reiterates | $50 → $82 | +227.35% | Oct 21, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $80 → $91 | Buy | Maintains | $80 → $91 | +263.27% | Oct 20, 2026 |
| Raymond James | Raymond James | Buy Maintains $75 → $86 | Buy | Maintains | $75 → $86 | +243.31% | Oct 20, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $40 → $66 | Buy | Maintains | $40 → $66 | +163.47% | Oct 20, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $51 → $50 | Buy | Reiterates | $51 → $50 | +99.60% | Oct 20, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $50 | Buy | Initiates | $50 | +99.60% | Oct 15, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.